{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:13:41Z","timestamp":1795194821439,"version":"4.10.3"},"reference-count":53,"publisher":"CSIRO Publishing","issue":"6","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":195,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"crossref","award":["No.82260613"],"award-info":[{"award-number":["No.82260613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"crossref","award":["No.2021D01A21"],"award-info":[{"award-number":["No.2021D01A21"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,23]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To describe the changes in cervical lesions prevalence and high-risk human papillomavirus (HR-HPV) infections from 2012 to 2021, which have never been reported before, to provide direction for the effective implementation of cervical cancer prevention measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included women aged &amp;gt;25\u00a0years who received either organised or opportunistic cervical HR-HPV screening from January 2012 to December 2021 in Karamay Central Hospital, Karamay, China. The patients were split into four groups according to age 25\u201335, 36\u201345, 46\u201355 and &amp;gt;55\u00a0years, respectively. The Joinpoint Regression Program was used to analyse the trends of HR-HPV infection and the detection of cervical lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 85,429 women revealed a decline in HR-HPV infection rates across all age groups from 2012 to 2021. Although HR-HPV infection rates decreased, cervical lesion detection rates increased, although the proportion of cervical cancer in these lesions declined, likely due to enhanced awareness and HPV vaccination in Karamay. From 2012 to 2021, the prevalence of low-grade squamous intraepithelial lesions was 9.70%, and high-grade squamous intraepithelial lesions was 5.85%. HR-HPV infections were highest in the \u226555\u00a0years age group, with HPV52 (20.96%) being the most prevalent type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the past 10\u00a0years, the prevalence of HR-HPV infection has shown a decreasing trend, whereas the detection prevalence of cervical lesions has shown an upward trend among women in Karamay City. Importantly, particular emphasis should be placed on cervical cancer screening in women aged &amp;gt;55\u00a0years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh24057","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:04:07Z","timestamp":1729555447000},"source":"Crossref","is-referenced-by-count":3,"title":["Trends in high-risk human papillomavirus infection and cervical cytology of women in Karamay City, 2012\u20132021"],"prefix":"10.1071","volume":"21","author":[{"given":"Xiaoping","family":"Jia","sequence":"first","affiliation":[{"name":"ADepartment of Gynecology, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang 524003, Guangdong, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[{"name":"BDepartment of Pathology, Karamay Hospital of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Karamay 834000, Xinjiang, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[{"name":"CDepartment of Gynecology, Karamay Hospital of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Karamay 834000, Xinjiang, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9049-5833","authenticated-orcid":true,"given":"Cailing","family":"Ma","sequence":"additional","affiliation":[{"name":"DDepartment of Gynecology, The First Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi 830011, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"issue":"3","key":"2025102419160195600_R1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2025102419160195600_R2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cam4.2697","article-title":"Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China.","volume":"9","author":"Duan","year":"2020","journal-title":"Cancer Med"},{"issue":"2","key":"2025102419160195600_R3","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"9895","key":"2025102419160195600_R4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer.","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"2025102419160195600_R5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8887672","article-title":"Cervical cancer screening guidelines in the postvaccination era: review of the literature.","volume":"2020","author":"Liverani","year":"2020","journal-title":"J Oncol"},{"issue":"9","key":"2025102419160195600_R6","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"2025102419160195600_R7","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2329450","article-title":"Opportunities and challenges for human papillomavirus vaccination in China.","volume":"20","author":"Zhao","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"2025102419160195600_R8","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01136-6","article-title":"Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward.","volume":"12","author":"Zhao","year":"2023","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2025102419160195600_R9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.","volume":"132","author":"Wheeler","year":"2013","journal-title":"Int J Cancer"},{"issue":"1","key":"2025102419160195600_R10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S0950268815000965","article-title":"Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.","volume":"144","author":"Dareng","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"3","key":"2025102419160195600_R11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/ijc.33278","article-title":"Population-based human papillomavirus infection and genotype distribution among women in rural areas of South Central Ethiopia.","volume":"148","author":"Teka","year":"2021","journal-title":"Int J Cancer"},{"issue":"1","key":"2025102419160195600_R12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/trstmh\/traa077","article-title":"Prevalence and genotype distribution of human papillomavirus infection in Huzhou City, eastern China, 2018\u20132019.","volume":"115","author":"Zhu","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"2025102419160195600_R13","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1080\/21645515.2019.1689743","article-title":"Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women.","volume":"16","author":"Yang","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"2025102419160195600_R14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210311","article-title":"HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong\u2019s largest independent pathology laboratory.","volume":"14","author":"Jiang","year":"2019","journal-title":"PLoS ONE"},{"issue":"1","key":"2025102419160195600_R15","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-019-1175-z","article-title":"Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.","volume":"16","author":"Zhang","year":"2019","journal-title":"Virol J"},{"issue":"4","key":"2025102419160195600_R16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/21645515.2020.1805993","article-title":"Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China.","volume":"17","author":"Mai","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"2025102419160195600_R17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230640","article-title":"HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.","volume":"15","author":"Hao","year":"2020","journal-title":"PLoS ONE"},{"issue":"4 Pt 2","key":"2025102419160195600_R18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/s0029-7844(98)00245-2","article-title":"Natural history of cervical squamous intraepithelial lesions: a meta-analysis.","volume":"92","author":"Melnikow","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025102419160195600_R19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","article-title":"Cervical cancer screening: a review.","volume":"330","author":"Perkins","year":"2023","journal-title":"JAMA"},{"key":"2025102419160195600_R20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"issue":"Suppl 7","key":"2025102419160195600_R21","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-3454-5","article-title":"Exploring the dynamics and interplay of human papillomavirus and cervical tumorigenesis by integrating biological data into a mathematical model.","volume":"21","author":"Wu","year":"2020","journal-title":"BMC Bioinformat"},{"issue":"2","key":"2025102419160195600_R22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/LGT.0000000000000382","article-title":"Low risk of cervical cancer\/precancer among most women under surveillance postcolposcopy.","volume":"22","author":"Demarco","year":"2018","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"2025102419160195600_R23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gocm.2023.10.005","article-title":"Guidelines for cervical cancer screening in China.","volume":"3","author":"Li","year":"2023","journal-title":"Gynecol Obstet Clin Med"},{"issue":"11","key":"2025102419160195600_R24","first-page":"1921","article-title":"Analysis of HPV infection characteristics and trend of cohort population in Karamay City, Xinjiang, 2010\u20132019 based on Joinpoint and APC Model.","volume":"49","author":"Nie","year":"2022","journal-title":"Mod Prevent Med"},{"issue":"3","key":"2025102419160195600_R25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"2025102419160195600_R26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1470-2045(19)30072-5","article-title":"Global elimination of cervical cancer as a public health problem.","volume":"20","author":"Brisson","year":"2019","journal-title":"Lancet Oncol"},{"issue":"5","key":"2025102419160195600_R27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/his.14609","article-title":"Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020).","volume":"80","author":"McCluggage","year":"2022","journal-title":"Histopathology"},{"issue":"1","key":"2025102419160195600_R28","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0282-3","article-title":"Cancer mortality in Serbia, 1991\u20132015: an age-period-cohort and joinpoint regression analysis.","volume":"38","author":"Ilic","year":"2018","journal-title":"Cancer Commun"},{"issue":"1","key":"2025102419160195600_R29","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-019-0785-3","article-title":"HPV genotype prevalence and distribution during 2009\u20132018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination.","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Women\u2019s Health"},{"issue":"10167","key":"2025102419160195600_R30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer.","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"2025102419160195600_R31","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1080\/21645515.2021.2007709","article-title":"Prevalence and genotype distribution of human papillomavirus infection among women aged 30\u201365 years in Xi\u2019an, China: a population-based study of 14,655 women.","volume":"17","author":"Han","year":"2021","journal-title":"Human Vaccin & Immunotherap"},{"issue":"12","key":"2025102419160195600_R32","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S1473-3099(16)30450-9","article-title":"Human papillomavirus vaccine approval in China: a major step forward but challenges ahead.","volume":"16","author":"Pan","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"2025102419160195600_R33","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer"},{"issue":"7","key":"2025102419160195600_R34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2025102419160195600_R35","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-021-01518-y","article-title":"Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014-2019.","volume":"18","author":"Li","year":"2021","journal-title":"Virol J"},{"key":"2025102419160195600_R36","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.710209","article-title":"HPV prevalence and genotype distribution among women from Hengyang district of Hunan Province, China.","volume":"9","author":"Tang","year":"2021","journal-title":"Front Public Health"},{"issue":"12","key":"2025102419160195600_R37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/dc.24891","article-title":"Prevalence and genotype distribution of high-risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014\u20132020.","volume":"49","author":"Luo","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"2025102419160195600_R38","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0998-5","article-title":"Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2025102419160195600_R39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial.","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"key":"2025102419160195600_R40","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.2147\/CMAR.S269050","article-title":"Prevalence and genotype distribution of high-risk human papillomavirus infection in women with abnormal cervical cytology: a population-based study in Shanxi Province, China.","volume":"12","author":"Song","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"23","key":"2025102419160195600_R41","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.7150\/jca.29034","article-title":"Influencing factors of high-risk human papillomavirus infection and DNA load according to the severity of cervical lesions in female coal mine workers of China.","volume":"10","author":"Lyu","year":"2019","journal-title":"J Cancer"},{"issue":"4","key":"2025102419160195600_R42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58081","article-title":"Prevalence of high-risk human papillomavirus infection, associated risk factors, and relationship with cervical precancerous lesions in perimenopausal and older women in an area with high cervical cancer incidence in China.","volume":"16","author":"Zhang","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"2025102419160195600_R43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217486","article-title":"High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N\u2019Djamena, Chad.","volume":"14","author":"Mboumba Bouassa","year":"2019","journal-title":"PLoS ONE"},{"issue":"3","key":"2025102419160195600_R44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/0956462412472446","article-title":"Multiple human papillomavirus infections and HIV seropositivity as risk factors for abnormal cervical cytology among female sex workers in Nairobi.","volume":"24","author":"Patel","year":"2013","journal-title":"Int J STD AIDS"},{"issue":"1","key":"2025102419160195600_R45","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05627-x","article-title":"High frequency of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico.","volume":"20","author":"Molina-Pineda","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"11","key":"2025102419160195600_R46","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"12","key":"2025102419160195600_R47","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"7413","key":"2025102419160195600_R48","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/488S2a","article-title":"HPV: The global burden.","volume":"488","author":"Crow","year":"2012","journal-title":"Nature"},{"issue":"7","key":"2025102419160195600_R49","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/cncr.32003","article-title":"The distribution and prevalence of human papillomavirus in women in mainland China.","volume":"125","author":"Li","year":"2019","journal-title":"Cancer"},{"key":"2025102419160195600_R50","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1225652","article-title":"HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China.","volume":"11","author":"Han","year":"2023","journal-title":"Front Public Health"},{"issue":"1","key":"2025102419160195600_R51","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2176009","article-title":"Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021.","volume":"12","author":"Yang","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"2025102419160195600_R52","unstructured":"Health Commission of Xinjiang Uygur Autonomous Region. Xinjiang\u2019s 249-valent HPV vaccine basically realizes full coverage of all prefectures (states and cities) and key counties (cities and districts). Available at https:\/\/wjw.xinjiang.gov.cn\/hfpc\/xwxc1\/202407\/35196c05ebb84263ab5ac0275d223d9f.shtml"},{"issue":"5","key":"2025102419160195600_R53","first-page":"576","article-title":"Reported routine immunization coverage with National Immunization Program vaccines in China, 2020\u20132021.","volume":"28","author":"Ye","year":"2022","journal-title":"Chinese J Vaccin Immuniz"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH24057\/150337\/sh24057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH24057\/150337\/sh24057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T23:16:11Z","timestamp":1761347771000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/21\/6\/SH24057\/21695\/Trends-in-high-risk-human-papillomavirus-infection"}},"subtitle":[],"editor":[{"given":"Eric P.F.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12,23]]}},"URL":"https:\/\/doi.org\/10.1071\/sh24057","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"article-number":"SH24057"}}